Baxter International Inc.
Narrative signal
Baxter International Inc.’s revenue growth stands at 2.7% for Dec 2024. Year-over-year, the metric shifted by −0.35 pts, translating into a −11.57% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
Valuation Signals
Track how the market prices earnings, book value, and operating cash flow for rapid context on relative multiples.
Price-to-Earnings Ratio
-22.9x
Price-to-Sales Ratio
1.4x
Price-to-Book Ratio
2.1x
EV / EBITDA
23.8x
Dividend Yield
4%
Profitability Pulse
Follow margin structure and return ratios that benchmark execution quality and capital efficiency.
Growth Momentum
Gauge the trajectory of revenue, earnings, and free cash flow expansion to understand durability.
Cash & Balance Sheet
Monitor liquidity, leverage, and free cash flow capacity that underpin resilience across cycles.
AlphaPilot quick take
• Baxter International Inc. trades at $18.48 with a market footprint around $9.5B.
• Operating within Healthcare — Medical - Instruments & Supplies offers instant peer context.
• Dashboard highlight: revenue growth at 2.7%, refreshed from the live fundamentals feed.
• Pivot into AlphaPilot deep dives to benchmark valuation, execution, and resilience.
Company profile
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc. (BAX) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Baxter International Inc. (BAX) stock price today?
Baxter International Inc. (BAX) trades near $18.48 as of Dec 4, 2025, 9:00 PM. Quotes refresh throughout the trading day in USD via Financial Modeling Prep, which powers the AlphaPilot dashboard.
What is Baxter International Inc.'s market capitalization?
Baxter International Inc.'s equity is valued around $9.5B, based on the latest share price multiplied by shares outstanding reported to Financial Modeling Prep.
What is the 52-week range for Baxter International Inc.?
Baxter International Inc.'s 52-week range runs from $17.40 — $37.74. Comparing the current price to this band helps visualize positioning versus the past year's highs and lows.
How active is trading in Baxter International Inc. stock?
Baxter International Inc. most recently moved about 6.9M shares. Elevated volume often signals strong investor interest or fresh catalysts.
Does Baxter International Inc. pay a dividend?
Baxter International Inc. currently yields roughly 4%. Dividend yield divides the last 12 months of payouts by the latest share price, providing a quick income snapshot.
What is Baxter International Inc.'s intraday trading range?
Baxter International Inc. has traded between $18.33 — $18.93 so far today. Monitoring the intraday span highlights short-term volatility relative to the longer 52-week range.
Where does the Baxter International Inc. stock data come from?
AlphaPilot sources quotes, fundamentals, and intraday chart data for Baxter International Inc. from the Financial Modeling Prep institutional API. The summary page blends live pricing with fundamentals that refresh after every earnings release or regulatory filing.